We are proud to have participated in the 3rd Annual Conference of the Association of Physicians of Al Ismailia, which took place on December 6 and 7 in Meknès.

This event, bringing together hundreds of healthcare professionals from various specialties, was a great opportunity to showcase our innovative solutions, particularly Mélatonine 1.9 mg LAPROPHAN, which continues to generate strong interest among physicians.

The discussions highlighted the benefits of melatonin as a safe alternative to anxiolytics, as well as its potential in other indications, such as relief from post-operative pain or even the treatment of hair loss. Innovative proposals, such as the development of effervescent tablets, reinforce our ambition to meet the expectations of healthcare professionals.

A highlight of these days was the symposium addressing sleep disorders in geriatrics and the positive impact of melatonin on the quality of life of elderly patients, safely.

Thank you to the Association of Physicians of Al Ismailia for this wonderful collaboration and to all the participants for their enriching exchanges. Together, let’s continue to innovate to meet the needs of patients and healthcare professionals.